ChlorquinaldolCAS# 72-80-0 |
- Dexpramipexole dihydrochloride
Catalog No.:BCC1528
CAS No.:104632-27-1
- Dexpramipexole
Catalog No.:BCC1527
CAS No.:104632-28-2
- Cariprazine hydrochloride
Catalog No.:BCC1454
CAS No.:1083076-69-0
- Cariprazine
Catalog No.:BCC1453
CAS No.:839712-12-8
Quality Control & MSDS
Chemical structure
3D structure
Number of papers citing our products
| Cas No. | 72-80-0 | SDF | Download SDF |
| PubChem ID | 6301 | Appearance | Powder |
| Formula | C10H7Cl2NO | M.Wt | 228.07 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Synonyms | 5,7-Dichloro-8-hydroxy-2-methylquinoline | ||
| Solubility | DMSO : 50 mg/mL (219.23 mM; Need ultrasonic) H2O : < 0.1 mg/mL (insoluble) | ||
| Chemical Name | 5,7-dichloro-2-methylquinolin-8-ol | ||
| SMILES | CC1=NC2=C(C=C1)C(=CC(=C2O)Cl)Cl | ||
| Standard InChIKey | GPTXWRGISTZRIO-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C10H7Cl2NO/c1-5-2-3-6-7(11)4-8(12)10(14)9(6)13-5/h2-4,14H,1H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Chlorquinaldol is a mono-hydroxyquinoline, is an antifungal and antibacterial, used for topical treatment of skin conditions and vaginal infections. |
Chlorquinaldol Dilution Calculator
Chlorquinaldol Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 4.3846 mL | 21.9231 mL | 43.8462 mL | 87.6924 mL | 109.6155 mL |
| 5 mM | 0.8769 mL | 4.3846 mL | 8.7692 mL | 17.5385 mL | 21.9231 mL |
| 10 mM | 0.4385 mL | 2.1923 mL | 4.3846 mL | 8.7692 mL | 10.9615 mL |
| 50 mM | 0.0877 mL | 0.4385 mL | 0.8769 mL | 1.7538 mL | 2.1923 mL |
| 100 mM | 0.0438 mL | 0.2192 mL | 0.4385 mL | 0.8769 mL | 1.0962 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Chlorquinaldol is an antimicrobial agent used for local antisepsy.
- Metandienone
Catalog No.:BCC9025
CAS No.:72-63-9
- 2,2-Bis(4-chlorophenyl)-1,1-dichloroethylene
Catalog No.:BCC8493
CAS No.:72-55-9
- 2,2-Bis(4-chlorophenyl)-1,1-dichloroethane
Catalog No.:BCC8492
CAS No.:72-54-8
- Alizarin
Catalog No.:BCN3479
CAS No.:72-48-0
- H-Thr-OH
Catalog No.:BCC3102
CAS No.:72-19-5
- H-Val-OH
Catalog No.:BCC3138
CAS No.:72-18-4
- Sulfathiazole
Catalog No.:BCC4859
CAS No.:72-14-0
- H-Thr(tBu)-OMe.HCl
Catalog No.:BCC3107
CAS No.:71989-43-0
- Fmoc-Tyr(Bzl)-OH
Catalog No.:BCC3564
CAS No.:71989-40-7
- Fmoc-Tyr(tBu)-OH
Catalog No.:BCC3567
CAS No.:71989-38-3
- Fmoc-Thr(tBu)-OH
Catalog No.:BCC3552
CAS No.:71989-35-0
- Fmoc-Ser(tBu)-OH
Catalog No.:BCC3544
CAS No.:71989-33-8
- 2-Geranyl-4-isobutyrylphloroglucinol
Catalog No.:BCN7170
CAS No.:72008-03-8
- Henryoside
Catalog No.:BCN4276
CAS No.:72021-23-9
- NHS-LC-Biotin
Catalog No.:BCC3579
CAS No.:72040-63-2
- Lochnericine
Catalog No.:BCN4595
CAS No.:72058-36-7
- Sepinol
Catalog No.:BCN4277
CAS No.:72061-63-3
- Spinosin
Catalog No.:BCN1644
CAS No.:72063-39-9
- 6,2',4'-Trimethoxyflavone
Catalog No.:BCC3897
CAS No.:720675-74-1
- 5(6)-Carboxyfluorescein
Catalog No.:BCC8283
CAS No.:72088-94-9
- Mastoparan X
Catalog No.:BCC5833
CAS No.:72093-22-2
- Prilocaine
Catalog No.:BCC4929
CAS No.:721-50-6
- Nerolidol
Catalog No.:BCN5459
CAS No.:7212-44-4
- b-Casomorphin (1-3)
Catalog No.:BCC1007
CAS No.:72122-59-9
Prevention and treatment of atrophic rhinitis in pigs with Getroxel, chlorquinaldol and oxytetracycline.[Pubmed:1838458]
Acta Vet Hung. 1991;39(3-4):127-35.
The sensitivity of ten Bordetella bronchiseptica and ten Pasteurella multocida strains, each isolated from cases of atrophic rhinitis (AR), was examined in tube dilution test. Getroxel, Chlorquinaldol and oxytetracycline and the former two ones combined with trimethoprim inhibited the growth of both species in vitro. The minimum inhibitory and the minimum bactericidal concentration was less than 0.5 microgram/ml. When efficacy was tested in SPF in the group fed a combination of Getroxel, Chlorquinaldol and oxytetracycline (60 mg, 240 mg and 360 mg/kg of feed, respectively), P. multocida disappeared from the nasal cavity by the end of a 30-day treatment. B. bronchiseptica was reisolated in low numbers from 2 out of 9 piglets. The daily body mass gain was by 7.9% higher and the feed conversion rate was by 19% better than in the control group. After slaughter, only mild signs of AR were seen in 3 out of 9 piglets treated with the above-mentioned drug combination, while in the control group severe lesions were observed in 8 out of 9 pigs. In treated commercial herds P. multocida disappeared from the nasal cavity of the piglets by the end of the treatment (42nd day of life), but the B. bronchiseptica strains could not be completely eliminated. Due to the treatment, mortality between 2 and 6 weeks of age decreased by 0.8-7.6%. Daily body mass gain was, on the average, 16.4% higher, the amount of feed needed for 1 kg body mass gain was by 15.3% lower and the duration of fattening was by 30.8 days shorter than in the control groups.
[In vitro activity of an antiseptic, chlorquinaldol, against Neisseria gonorrhoeae and Chlamydia trachomatis].[Pubmed:1901985]
Pathol Biol (Paris). 1991 Feb;39(2):136-9.
The activity of Chlorquinaldol, a derivative of hydroxy-8-quinolein used for local antisepsy, was studied against Neisseria gonorrhoeae and Chlamydia trachomatis. The weak solubility of the product and the special growth conditions of the organisms made an adaptation of the AFNOR norm necessary. For 0.1 to 0.2% (W/V) Chlorquinaldol concentrations, a reduction of about 10(4) organisms was obtained after 60 minutes for N. gonorrhoeae and C. trachomatis. However, for technical problems, the concentrations tested were 10 to 100 times lower than the doses usually recommended for this antiseptic.
